FIELD: biotechnology.
SUBSTANCE: method of classifying molecular subtypes of gastric cancer by immunohistochemical testing is described, the said method involves an original algorithm for step-by-step immunohistochemical testing of gastric cancer, including a panel of the following markers: MSH2, MSH6, MLH1, PMS2, MUC2, CDX2, MUC5AC, CD10, E-cadherin, β-catenin, Claudin-1, Claudin-3, Claudin-4, CD44, LMP-1, EBER, p53, PD-L1, CD4, CD8, CD68, CD1a. The method makes it possible to identify 5 molecular subtypes of gastric cancer with significantly different clinical, morphological and prognostic characteristics. The algorithm provides for the identification of the MMR-negative subtype at the first stage, the EBER-positive subtype at the second stage, then the E-cadherin-aberrant subtype, then the CDX2-positive subtype and the CDX2-negative subtype, since in this option the differences between the subtypes are of the greatest significance (p=0.001).
EFFECT: invention expands the range of diagnostic tools for stomach cancer.
4 cl, 6 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING THERAPEUTIC APPROACH IN PATIENTS WITH METASTATIC FORMS AND RECURRENT TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2818730C1 |
METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
METHOD FOR PREDICTING THE DURATION OF A RELAPSE-FREE PERIOD IN PATIENTS WITH RESECTABLE THRICE-NEGATIVE BREAST CANCER | 2021 |
|
RU2780922C1 |
METHOD OF CREATING TARGET PANEL FOR STUDYING GENOMIC REGIONS FOR DETECTING THERAPEUTIC BIOMARKERS OF IMMUNE CHECKPOINT (IC) INHIBITORS | 2023 |
|
RU2818360C1 |
METHOD FOR PREDICTION OF EFFECTIVENESS OF CONSERVATIVE TREATMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2023 |
|
RU2817324C1 |
METHOD FOR VISUAL SEMI-QUANTITATIVE EVALUATION OF CDX-2 PROTEIN EXPRESSION IN TISSUES BY IMMUNOHISTOCHEMICAL METHOD | 2020 |
|
RU2758888C1 |
METHOD OF PREDICTING RESISTANCE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER | 2022 |
|
RU2802671C1 |
BIOMARKER PANEL AND METHODS FOR DETECTING MICROSATELLITE INSTABILITY IN VARIOUS TYPES OF CANCER | 2019 |
|
RU2795410C2 |
METHOD FOR COMBINED TREATMENT OF OPERABLE STOMACH CANCER WITH A POSITIVE PDL STATUS | 2020 |
|
RU2756870C1 |
METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS OF DIFFUSE GASTRIC CANCER | 2012 |
|
RU2493568C1 |
Authors
Dates
2024-02-15—Published
2023-08-03—Filed